This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Non-steroidal anti-inflammatory drug (NSAID) in patients with a prior myocardial infarction (MI)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

A Danish cohort study has suggested that the use of NSAID's in patients with prior MI is associated with an increased risk of death or recurrent myocardial infarction.

  • the risk was largely independent of the duration of the treatment and was evident within the first few weeks of commencing treatment
  • an increase in cardiovascular events was seen with both coxibs (e.g. celecoxib, etoricoxib) and traditional NSAID's (e.g. diclofenac, naproxen and ibuprofen)
    • the highest risk of death or recurrent MI was seen with the use of diclofenac while a lowest risk was associated with naproxen (1)

In patients whom NSAID's are required, safety profiles of individual NSAIDs and individual patient risk factors should be taken into consideration before prescribing

  • low-dose ibuprofen (<=1200 mg/day) - is a suitable first choice NSAID due to its low risk of gastrointestinal and cardiovascular side effects
  • low-dose ibuprofen or naproxen 1000 mg/ day - more suitable when CV risk is a significant consideration in decision making (1).

Although the risk of gastrointestinal side effects is lower in coxibs (compared to traditional NSAID's), the use of coxibs alone ahead of traditional NSAIDs (with a PPI) is not considered due to the lack of supporting evidence (1).

The cardiovascular risk for coxibs was higher than ibuprofen <=1200 mg/ day or naproxen 1000 mg/day (1)

Hence this study provides further evidence to the existing advice that the use of NSAID's should be at the lowest effective dose and limited to the shortest time necessary to control symptoms (1)

Reference:

  • 1. National Prescribing Centre (NPC). MeReC monthly 2011;42

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.